Connor, Clark & Lunn Investment Management (CC&L)’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,724
| Closed | -$210K | – | 1517 |
|
|
2022
Q4 | $210K | Sell |
9,724
-337
| -3% | -$7.28K | ﹤0.01% | 1047 |
|
|
2022
Q3 | $195K | Buy |
+10,061
| New | +$195K | ﹤0.01% | 996 |
|
|
2022
Q2 | – | Sell |
-18,197
| Closed | -$543K | – | 1248 |
|
|
2022
Q1 | $543K | Buy |
18,197
+1,440
| +9% | +$43K | ﹤0.01% | 771 |
|
|
2021
Q4 | $390K | Buy |
+16,757
| New | +$390K | ﹤0.01% | 847 |
|